Glucose En Natriumchloride

Glucose En Natriumchloride is an intravenous injection solution that combines sodium chloride and glucose monohydrate. It is supplied without a specified strength and is marketed in the European Union for use under prescription. The formulation is designed to deliver both an electrolyte and a carbohydrate source directly into the bloodstream, supporting fluid balance and energy needs in clinical settings.

Glucose En Natriumchloride is indicated for several clinical situations where fluid, electrolyte, and glucose replacement are required.

- Restoration of intravascular volume in patients with dehydration or blood loss. - Correction of hyponatremia or low sodium levels. - Management of hypoglycemia when oral glucose is not feasible. - Supplementation of parenteral nutrition regimens. - Support during surgical procedures or intensive care where intravenous fluids are needed. - Use as a carrier for other intravenous medications when compatible.

Side effects of Glucose En Natriumchloride may vary in frequency and severity.

Common: - Local irritation or pain at the injection site. - Mild hyperglycemia or elevated blood glucose levels. - Transient increase in serum sodium concentration. - Nausea or mild gastrointestinal discomfort. - Headache or dizziness related to fluid shifts.

Serious: - Severe hypernatremia leading to neurological symptoms. - Acute pulmonary edema from rapid volume overload. - Allergic reaction or anaphylaxis. - Significant hyperglycemia requiring medical intervention. - Electrolyte imbalance causing cardiac arrhythmias.

When using Glucose En Natriumchloride, clinicians should consider several safety measures.

- Assess baseline electrolyte levels and blood glucose before administration. - Adjust infusion rate in patients with heart failure or renal impairment to avoid fluid overload. - Monitor serum sodium and glucose regularly during therapy. - Use caution in patients with known hypersensitivity to sodium chloride or glucose solutions. - Avoid rapid bolus administration unless specifically indicated. - Ensure proper aseptic technique to prevent infection at the infusion site. - Review concomitant medications that may affect fluid or electrolyte balance.

Glucose En Natriumchloride can interact with other drugs, influencing safety and efficacy.

Avoid: - Concurrent use of high-dose insulin without glucose monitoring, which may precipitate severe hypoglycemia. - Administration with hypertonic saline solutions that could exacerbate hypernatremia.

Use with caution: - Diuretics that increase sodium loss, requiring closer electrolyte monitoring. - Medications that affect cardiac conduction (e.g., digoxin) when electrolyte shifts are possible. - Steroids or catecholamines that raise blood glucose levels. - Renal replacement therapies that alter fluid and electrolyte status. - Blood products that may affect volume status when given together.